Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James C Patti

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Science Immunology|July 5, 2020
Let's talk about sexJames C Patti, Gabriel K Griffin
Hepatobiliary Surgery and Nutrition|August 30, 2017
Value-based assessment of robotic pancreas and liver surgeryJames C Patti, Ana Sofia Ore, Courtney Barrows, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 2, 2022
Endothelial Cell Insulin Signaling Regulates CXCR4 (C-X-C Motif Chemokine Receptor 4) and Limits Leukocyte Adhesion to EndotheliumThomas Rathjen, Britta Kunkemoeller, Carly T Cederquist, et al.
Nature|May 6, 2021
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicityGabriel K Griffin, Jingyi Wu, Arvin Iracheta-Vellve, et al.
Nature|October 4, 2023
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunityChristina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Science Immunology|July 5, 2020
Let's talk about sexJames C Patti, Gabriel K Griffin
Hepatobiliary Surgery and Nutrition|August 30, 2017
Value-based assessment of robotic pancreas and liver surgeryJames C Patti, Ana Sofia Ore, Courtney Barrows, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 2, 2022
Endothelial Cell Insulin Signaling Regulates CXCR4 (C-X-C Motif Chemokine Receptor 4) and Limits Leukocyte Adhesion to EndotheliumThomas Rathjen, Britta Kunkemoeller, Carly T Cederquist, et al.
Nature|May 6, 2021
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicityGabriel K Griffin, Jingyi Wu, Arvin Iracheta-Vellve, et al.
Nature|October 4, 2023
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunityChristina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, et al.
Pageof 1